Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.225 USD | -7.29% | -7.05% | +24.44% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 59.55M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -70M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.79
x | P/E ratio 2025 * |
-2.67
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.57% |
Latest transcript on Eledon Pharmaceuticals, Inc.
Current month | +0.84% | ||
1 month | +43.45% | ||
3 months | +37.71% | ||
6 months | +107.76% | ||
Current year | +33.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.24 | -6.67% | 138 607 |
24-05-09 | 2.4 | -1.64% | 171,171 |
24-05-08 | 2.44 | +7.96% | 405,517 |
24-05-07 | 2.26 | -7.38% | 2,532,836 |
24-05-06 | 2.44 | +1.24% | 92,932 |
Delayed Quote Nasdaq, May 10, 2024 at 09:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.89% | 59.55M | |
+2.78% | 108B | |
+10.25% | 104B | |
+2.42% | 22.33B | |
-11.94% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-8.89% | 17.64B | |
+6.52% | 14.05B | |
+35.94% | 12.51B |
- Stock Market
- Equities
- ELDN Stock